CANSINO BIOLOGICS IN

6185
End-of-day quote. End-of-day quote  - 09/24
280.2HKD -0.64%
Prev.282.0000
Open282.0000
High289.4000
Low277.2000
Volume593 772
Latest news
2d ago
6d ago
09/10
09/07
Chart CANSINO BIOLOGICS INC.
Technical analysis trends
Short TermMid-TermLong Term
TrendBearishNeutralBullish
Resistance289422422
Spread/Res.-3,1%-34%-34%
Spread/Supp.7,5%7,5%11%
Support261261252
Financials
Sales 2021 9 984 M 1 544 M 1 544 M
Net income 2021 5 282 M 817 M 817 M
Net cash 2021 5 073 M 785 M 785 M
P/E ratio 2021 11,6x
Yield 2021 0,00%
Capitalization 38 163 M 5 902 M 5 902 M
EV / Sales 2021 3,31x
EV / Sales 2022 0,88x
Nbr of Employees 726
Free-Float 37,1%
Company
CanSino Biologics Inc is a clinical-stage vaccine company in China. The Company's products include Ad5-EBOV vaccine used for Ebola virus, MCV2 and MCV4 vaccines for meningococcus, PBPV vaccine used for pneumococcal and the recombinant novel coronavirus vaccine. Its products are mainly used in...

>> Read more
Sector :
Biopharmaceuticals
Calendar :
No events available
Trading Rating :
Investor Rating :

Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 8
Last Close Price 232,71 CNY
Average target price 308,77 CNY
Spread / Average Target 32,7%